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Abstract
Background: Sepsis and jaundice are common conditions in newborns that can lead to brain damage. Though
lipopolysaccharide (LPS) is known to alter the integrity of the blood-brain barrier (BBB), little is known on the effects of
unconjugated bilirubin (UCB) and even less on the joint effects of UCB and LPS on brain microvascular endothelial cells
(BMEC).
Methodology/Principal Findings: Monolayers of primary rat BMEC were treated with 1 mg/ml LPS and/or 50 mM UCB, in the
presence of 100 mM human serum albumin, for 4 or 24 h. Co-cultures of BMEC with astroglial cells, a more complex BBB
model, were used in selected experiments. LPS led to apoptosis and UCB induced both apoptotic and necrotic-like cell
death. LPS and UCB led to inhibition of P-glycoprotein and activation of matrix metalloproteinases-2 and -9 in mono-
cultures. Transmission electron microscopy evidenced apoptotic bodies, as well as damaged mitochondria and rough
endoplasmic reticulum in BMEC by either insult. Shorter cell contacts and increased caveolae-like invaginations were
noticeable in LPS-treated cells and loss of intercellular junctions was observed upon treatment with UCB. Both compounds
triggered impairment of endothelial permeability and transendothelial electrical resistance both in mono- and co-cultures.
The functional changes were confirmed by alterations in immunostaining for junctional proteins b-catenin, ZO-1 and
claudin-5. Enlargement of intercellular spaces, and redistribution of junctional proteins were found in BMEC after exposure
to LPS and UCB.
Conclusions: LPS and/or UCB exert direct toxic effects on BMEC, with distinct temporal profiles and mechanisms of action.
Therefore, the impairment of brain endothelial integrity upon exposure to these neurotoxins may favor their access to the
brain, thus increasing the risk of injury and requiring adequate clinical management of sepsis and jaundice in the neonatal
period.
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Introduction
The blood-brain barrier (BBB) is a dynamic interface between
blood and brain compartments that protects nerve tissue from
insults. Brain microvascular endothelial cells (BMEC), possessing
unique properties, are considered the main constituents of the
barrier. They regulate the selective passage of substances through
the expression of specific influx and efflux transport systems [1].
ATP-binding cassette (ABC) transporters, such as the efflux
transporter P-glycoprotein (P-gp), export potentially toxic com-
pounds. A relevant transcellular vesicular transport mechanism at
the BBB occurs through caveolae, which are dynamic pieces of
membrane enriched in cholesterol and sphingolipids, as well as in
the structural protein caveolin-1 [1]. Additionally, BMEC display
cohesive intercellular junctional complexes, composed of tight
junctions (TJs) and adherens junctions (AJs). TJs are formed by
transmembrane proteins like claudins, occludin, tricellulin,
junctional adhesion molecules, and cytoplasmic proteins, like the
zonula occludens (ZO) family [2]. TJs are responsible for high
transendothelial electrical resistance (TEER) and low paracellular
permeability at the BBB [3,4]. AJs are constituted by the
transmembrane proteins vascular endothelial cadherins, nectins,
platelet-endothelial cell adhesion molecule, and by the cytoplas-
mic catenins, comprising b-catenin [5]. BMEC, pericytes and
astrocytes share a thick basement membrane that is composed of
various extracellular matrix (ECM) classes of molecules [1].
Matrix metalloproteinases (MPPs) are known to digest basement
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conditions affecting the integrity of intercellular junctions, BBB
transporters or the basement membrane impair the barrier
function of the BBB, which can lead to or further increase brain
damage.
Sepsis reflects an uncontrolled systemic inflammatory response
to an infection that can cause organ dysfunction, eventually
leading to shock or even death [6]. Lipopolysaccharide (LPS) is the
major component of the outer membrane of Gram-negative
bacteria. It may circulate in low levels in the blood in certain
diseases [7], but high levels suggest infection or sepsis. Rat BMEC
have been shown to express the Toll-like receptors (TLR) 2, 3, 4, 6
and the membrane cluster of differentiation 14 (CD14), which
binds LPS [8,9]. When activated, these receptors trigger the
release of pro-inflammatory cytokines into the brain parenchyma
and induce neuroinflammation. Our previous studies have shown
that binding of LPS to rat primary BMEC co-cultured with
astrocytes leads to increased permeability, reduced TEER,
alterations in intercellular junctions assembly, as well as to
inhibition of P-gp activity [10]. These changes in BBB integrity
may favor the access of neurotoxins as well as of microbial
pathogens to the brain [7].
Unconjugated bilirubin (UCB), the principal end product of
heme catabolism, circulates in the plasma almost entirely bound to
albumin due to its low solubility in aqueous medium, and the
concentrations of unbound (free) bilirubin are in the nM range
[11]. At low or slightly elevated concentrations as those reported
for Gilbert patients, who present up to 100 mM total serum
bilirubin and a UCB to albumin molar ratio of 0.2, UCB is
a powerful antioxidant, able to provide protection against
cardiovascular diseases and cancer [12–14]. It was also shown
that UCB formed by upregulation of heme oxygenase-2, which is
constitutive and highly concentrated in neurons, protects these
nerve cells from H2O2-induced loss of cell viability. However, at
higher concentrations, UCB is no longer beneficial but instead
induces neuronal death [15]. This dual behavior was observed in
our own laboratory, where 10 nM free UCB were shown to
protect neurons from H2O2-induced neuronal death, nuclear
factor (NF)-KB activation and tumor necrosis factor (TNF)-
a secretion, whereas 100 nM was neurotoxic [16]. These
observations support the notion that UCB acts as a double-edged
sword, either beneficial at low concentrations, or detrimental at
elevated levels. Accordingly, in the experimental conditions that
we have been consistently using with different cell types [17–19],
which reproduce a moderate or severe hyperbilirubinemia [UCB
to human serum albumin (HSA) molar ratios of 0.5 and 1.0,
respectively], toxicity is observed and oxidative stress appears as
a relevant event [20–22]. Hyperbilirubinemia is particularly
common in the neonatal period due to the shorter life span of
fetal erythrocytes, together with the immaturity of the hepatic
clearance system [12]. These high levels of UCB become
neurotoxic by inducing oxidative and nitrosative stress, mainly
in neurons [23,24], and the release of pro-inflammatory cytokines
by astrocytes [25] and microglia [26]. Our most recent studies
revealed that human BMEC exposed to UCB are also under
nitrosative stress, as indicated by the upregulation of endothelial
nitric oxide synthase and production of nitrites, the end-product of
nitric oxide, and release cytokines, such as the vascular endothelial
growth factor and interleukin (IL)-6 [27]. Interestingly, both nitric
oxide and these cytokines are known to increase BBB permeability
[28,29]. Despite such indication of a hyperpermeability of the BBB
upon exposure to UCB, direct evidence of the disruption of the
barrier properties by UCB exposure has never been provided.
Hyperbilirubinemia and sepsis frequently occur as associated
pathological conditions in newborn infants. Sepsis is considered as
a neurotoxicity risk factor during neonatal hyperbilirubinemia [30]
and a recent prospective study indicated that jaundiced infants
with encephalopathy were more likely to have a coexistent
infection than hyperbilirubinemic infants without brain damage
[31]. Our previous studies showed that the inflammatory response
and cell death in astrocytes are exacerbated by LPS [17,32].
However, the effects produced by the combination of these
compounds have never been studied in BMEC.
The aim of this study was to reveal the effects of LPS and UCB,
alone or in combination, on the morphological and functional
characteristics of rat BMEC in conditions mimicking sepsis and
moderate to severe hyperbilirubinemia.
Results
LPS, UCB and their Combination Induce Cell Death in Rat
BMEC
Primary cultures of rat BMEC are commonly used as simplified
in vitro models of the BBB (for review see [29,33]). In order to
evaluate the impairment of rat BMEC viability by exposure to
LPS and UCB, we assessed necrosis-like cell death by determining
the release of intracellular lactate dehydrogenase (LDH) into the
incubation medium. As seen in Fig. 1A, LPS triggered a mild,
though not statistically significant, elevation of LDH release, which
attained maximum levels of 9.4% and 16.2% at 4 and 24 h,
respectively, corresponding to an overall time-dependent elevation
(P,0.01) in the extent of cell death. With UCB, higher values were
achieved (16.9% at 4 h and 21.4% at 24 h, P,0.01 and P,0.05,
respectively, as compared to the respective control), reflecting
a time-dependent loss of cell viability (P,0.05). There was no
aggravation in necrosis-like cell death when cells were exposed to
both LPS and UCB (LDH release at 24 h: 20.3%, P,0.05 as
compared to the respective control), even though it similarly
increased with the time of exposure (P,0.01).
Either UCB or LPS induced apoptosis in BMEC, as observed
by staining endothelial nuclei with Hoechst 33258 dye followed by
analysis of nuclear morphological features (Figs. 1B,C), in
accordance with previous demonstrations [27,34]. LPS induced
apoptotic cell death in a time-dependent manner (P,0.01),
reaching 18.0% (P,0.05) after 24 h treatment. When exposed
to UCB, the percentage of cells with apoptotic morphology was
already significantly increased at 4 h (19.6%, P,0.001) and
sustained at 24 h (20.7%, P,0.001). As for LDH, there was no
increment in UCB-induced apoptotic cell death by co-incubation
with LPS. In contrast, apoptosis raised from 13.1% in LPS-treated
cells to 18.7% in cells treated with both LPS and UCB for 4 h
(P,0.01 as compared to LPS alone). To note that this difference
disappeared as the incubation was extended to 24 h and death
continued to increase in cells treated with LPS alone.
We also studied the activity of caspase-3 (Fig. 1 D). LPS induced
no significant alterations in caspase-3 activity at the time-points
studied, reaching a maximum elevation of 1.2-fold at 4 h. On the
other hand, cells exposed to UCB had a significant increase in
caspase-3 activity at the earliest time-point, attaining 1.9- and 2.0-
folds for UCB and UCB with LPS, respectively (P,0.05). At 24 h
cells treated with UCB alone revealed a sustained caspase-3
activity (1.7-fold, P,0.05).
Activity of ABC Transporter P-gp is Impaired by LPS and
UCB
We studied the effects of LPS and UCB on the efflux transporter
P-gp activity (Fig. 2), based on the measurement of cellular
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used to assess P-gp function. Accumulation of the substrate reflects
a decreased activity of the efflux transporter, as have been
recognized and used, particularly in primary cultures of BMEC
[10,35]. Results were expressed as fold-change from control,
which presented ,114 ng R123/mg protein. P-gp activity was
already diminished following 4 h exposure to LPS or UCB, as
indicated by the 1.2-fold elevation in intracellular levels of R123
(P,0.05). Exposure to both LPS and UCB increased P-gp
inhibition with time (P,0.05) and aggravated the inhibition
induced by LPS alone at 24 h (1.2-fold for LPS vs. 1.4-fold for LPS
plus UCB, P,0.05).
Activities of MMP-2 and MMP-9 are Increased by LPS and
UCB
It has been known that the release of active MMPs is related to
the opening of the BBB in LPS-injured brain tissue [36]. The
activities of MMP-2 and MMP-9 released by rat BMEC after
exposure to the insults were similar (Fig. 3). Significant increases in
the activity of secreted MMPs were already observed at 4 h for
both LPS (1.7-fold for MMP-9 and 1.8-fold for MMP-2, P,0.05)
and UCB (1.9-fold for MMP-9 and MMP-2, P,0.05), which were
less marked at 24 h treatment though still statistically significant.
No significant aggravation of the effect was observed by
simultaneous exposure to both neurotoxins, either at 4 or at 24 h.
Figure 1. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) induce cell death in brain microvascular endothelial cells.
Culture medium was collected for determination of lactate dehydrogenase (LDH) activity (A). Nuclei were stained with Hoechst 33258 dye and
morphological features of apoptosis are pointed (arrows) (B). The number of apoptotic nuclei was counted and results were expressed as percentage
of the total number of nuclei (C). Cell lysates were obtained for caspase-3 activity determination (D). Results are mean 6 S.E.M. from at least five
independent experiments performed in duplicate. Scale bar, 20 mm. *P,0.05, **P,0.01 and ***P,0.001 vs. respective control;
1P,0.05,
11P,0.01 vs.
LPS at the same time-point;
#P,0.05 and
##P,0.01 from 4 h.
doi:10.1371/journal.pone.0035919.g001
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Transmission electron microscopy (TEM) investigated in detail
the impairment of rat BMEC monolayers exposed to the
neurotoxins (Fig. 4). In cell cultures treated with LPS or UCB,
several signs of cell damage and the presence of apoptotic bodies
released by rat BMEC were detected, confirming the occurrence
of apoptotic processes. Our observations include heavily damaged
mitochondria that were swollen and more electron dense than in
control cells, indicating an impairment in mitochondrial function
in both conditions. In addition, the rough endoplasmic reticulum
was typically swollen in the treated cells. This alteration may
indicate a lesion of the synthesis of lipids or metabolism of sugars,
and also impairment in their detoxification function. Moreover, it
was observed irregularly shaped vacuoles and holes in the
cytoplasm, together with unevenness and little projections instead
of a rather smooth, elongated shape of the rat capillary endothelial
cell. Appearance and abundance of caveolae-like invaginations in
the plasma membrane was frequently found in LPS-treated cells,
an effect that was not so evident in cells incubated with UCB.
TEM analysis revealed shortened extension of intercellular
contacts in LPS-treated cells and no intact cell-cell junctions
could be detected in UCB-treated cells.
Exposure to LPS and UCB Impair the Barrier Function of
Rat BMEC
TEER and paracellular permeability to small molecule tracers
provide information on barrier integrity in various in vitro BBB
models [29,33,37]. We have demonstrated that LPS treatment
caused a concentration- and time-dependent decrease in TEER
and increased permeability to tracers in rat BMEC co-cultured
with astrocytes [10], but, so far, such features have not been
explored in cells exposed to UCB or to both neurotoxins, either in
co-cultures or in BMEC mono-cultures.
Permeability to sodium fluorescein (Na-F) was of
,1.9610
25 cm/s in control BMEC monolayers. LPS exposure
induced an elevation of permeability to 3.4610
25 cm/s at 4 h
(P,0.01), and only a moderate increase after 24 h exposure
(2.1610
25 cm/s, P,0.05 vs. 4 h) (Fig. 5A). Similarly, cells treated
with UCB showed an increased permeability at 4 h treatment
(4.0610
25 cm/s, P,0.01), with a sustained effect at 24 h.
Alterations in permeability were significantly higher after simul-
taneous exposure to both insults at 24 h compared to those treated
with LPS alone (P,0.05).
TEER was assessed after exposure to LPS and/or UCB for 4 h
and 24 h (Fig. 5B), and results were compared with those obtained
in controls (,42 V cm
2 after subtracting the values of cell free
inserts). LPS treatment led to a significant decrease in TEER after
4 h exposure (20 V cm
2, P,0.01) and monolayers partially
recovered from the early onset damage at 24 h, as indicated by
higher resistance levels (36 V cm
2, P,0.05 vs. 4 h).
On the other hand, UCB caused lower values through longer
periods of exposure, as indicated by the TEER decrease at 4 h
(24 V cm
2, P,0.05) and at 24 h (21 V cm
2, P,0.001). In-
cubation with both LPS and UCB for 24 h did not aggravate
UCB-induced effect, but TEER values were significantly lower
than for 24 h treatment with LPS alone (P,0.01 as compared to
the respective control, and P,0.05 from LPS alone).
Co-cultures of BMEC with astrocytes are accepted as more
complex and tighter in vitro models of the BBB since astrocytes
induce the barrier properties of BMEC [1,29,33]. To reinforce our
observations, a set of experiments was performed in rat BMEC co-
cultured with glial cells where the paracellular permeability to Na-
F and the TEER were assessed 24 h after treatment (Fig. 6). In co-
cultures, untreated BMEC had higher TEER (233 V cm
2) and
lower permeability (2.1610
26 cm/s) values than mono-cultures.
The permeability pattern was similar to that of mono-cultures,
though in general 2-fold greater and there was a significant
increase induced by LPS. Regarding TEER, the response to the
neurotoxins was also similar in both models, but the alterations
resulting from the presence of astrocytes were more modest as
compared with mono-cultures, as well as in comparison with those
observed for permeability, particularly in UCB-treated cells.
Junctional Proteins in Rat BMEC are Altered by LPS and
UCB
Cellular expression and localization of the AJ protein b-catenin
was also assessed in mono-cultures both at 4 h and at 24 h (Fig. 7).
After LPS treatment cell contours were hardly visible at 4 h, whilst
b-catenin was relocated at the membrane at 24 h. b-catenin
appeared as small dots in LPS-treated cells, which were
particularly evident at 4 h incubation, contrasting with the normal
staining observed in control cells. Treatment with UCB also
revealed alterations in the distribution of b-catenin, which varied
with the time of exposure. In fact, a short incubation led to
a transient translocation of the protein from the membrane to the
cytosol; this effect appears to be transient as at 24 h the presence of
the protein was clearly noticed at intercellular contacts. In-
terestingly, an overall increase in fluorescence intensity of b-
catenin was detected in cells treated for 24 h with UCB (1.3-fold
from control, P,0.01), whereas a decrease was observed for LPS
(0.7-fold, P,0.01). As a result of these opposite variations, no
significant change in the fluorescence intensity was observed in
cells simultaneously treated with LPS and UCB.
Disorganization of the monolayer together with gaps between
endothelial cells was also detected in cells exposed to the
neurotoxins. In rat BMEC co-cultured with astrocytes not treated
with LPS or UCB (control) for 24 h, b-catenin was mainly located
at the plasma membrane. Compared to mono-cultures, LPS-
treated cells also showed greater expression of b-catenin but with
Figure 2. Lipopolysacharide (LPS) and unconjugated bilirubin
(UCB) inhibit P-glycoprotein (P-gp) activity in brain microvas-
cular endothelial cells. To evaluate if P-gp is functioning properly, it
was measured the protein’s ability to remove the substrate rhodamine
123 (R123). After treatment, cells were incubated for 30 min with 10 mM
R123. Total protein extracts were collected, R123 accumulation
fluorescent emission was determined and results were expressed per
mg of protein. Values presented are means 6 S.E.M., from at least four
independent experiments performed in duplicate. *P,0.05, **P,0.01
and ***P,0.001 vs. respective control;
1P,0.05 vs. LPS at the same
time-point;
#P,0.05 from 4 h.
doi:10.1371/journal.pone.0035919.g002
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hand, the intensity of b-catenin immunostaining in the cytoplasm
was weaker and that at the cell contours was greater than in mono-
cultured cells at the same period. In BMEC treated with LPS and
UCB, b-catenin was noticeable not only at the plasma membrane
but also in the cytosol including the perinuclear region. Moreover,
the staining revealed intercellular gaps.
Immunostaining for TJ proteins ZO-1 and claudin-5 was
performed in mono-cultures and co-cultures after 24 h of
treatment with the neurotoxins (Figs. 8 and 9). In control cells,
the contour line observed for ZO-1 appeared thicker in co-
cultures than in mono-cultures, similarly to that observed for b-
catenin. Despite the beautiful labeling obtained for claudin-5 in
mono-culture control cells, the contours appeared lighter than in
co-cultures. Moreover, the staining observed in the cytosol nearly
disappeared in co-cultures and, therefore, the main immunos-
taining was at the plasma membrane when endothelial cells were
co-cultured with astrocytes, for both ZO-1 and claudin-5. In
mono-cultures, cells exposed to LPS or UCB alone, or to their
combination, showed altered morphology and staining patterns
for ZO-1 and claudin-5, as compared with untreated cells that
showed elongated shape and well delineated contours. Cells
treated with UCB, or its combination with LPS, showed
fragmented staining for claudin-5, suggesting an impairment of
the intercellular junctions. Moreover, spaces were visible between
adjacent cells, further confirming the damaged connection
between cells following treatment with the insults. Unlike the
simplified model, co-cultured cells treated with LPS looked more
altered at this time-point. They showed large spaces between
cells and less staining for ZO-1 at the membrane, with more
cytoplasmic and perinuclear immunoreactivity. On the other
hand, UCB seemed to have a greater effect on claudin-5 with
a decrease in plasma membrane immunoreactivity.
Discussion
In the present study, confluent monolayers of primary rat
BMEC were used alone or in co-culture as in vitro models of the
BBB. The integrity of the endothelial barrier and its functional
and morphological characteristics were evaluated after treatment
Figure 3. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) activate metalloproteinase-9 (MMP-9) and metalloprotei-
nase-2 (MMP-2) released by brain microvascular endothelial cells. A representative gel from one experiment is shown, where MMP-2 and
MMP-9 were identified by their apparent molecular mass of 67 and 92 kDa, respectively (A). The intensity of the bands was quantified by scanning
densitometry and results for MMP-9 (B) and MMP-2 (C) were standardized with respect to total protein content. Results are mean 6 S.E.M. from at
least four independent experiments performed in duplicate. *P,0.05 and **P,0.01 vs. respective control;
##P,0.01 from 4 h.
doi:10.1371/journal.pone.0035919.g003
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primary rat BMEC is significantly modified by UCB and by
both insults combined, but that at least 77% of cells are viable,
which is a desirable experimental condition to perform
functional studies such as the assessment of P-gp and MMPs
activities. Necrotic-like cell death induced by the same
concentration of LPS was reported in transformed bovine
BMEC by Karahashi et al. [38], though the extent was over
40% at 24 h and no significant damage was seen at 4 h. Such
divergent viability data may not only reflect different reactions
to neurotoxins between species and between cell lines and
primary cultures [39], but can mostly be due to the fact that
this study was performed with medium supplemented with 10%
FBS, unlike our own models. In studies performed in similar
conditions to ours, namely with no addition of soluble CD14,
there is also little LPS-induced LDH release for up to 16 h,
being this the maximum time studied [34]. Still, our conditions
are suitable for LPS interaction with BMEC given that our
medium contains 2% FBS, which has soluble CD14, and that
EC also express membrane CD14 in the presence of LPS [8].
LDH release induced by UCB is in agreement with our
previous observations in a cell line of human BMEC [27],
although in a slightly different range. Apoptotic cell death
resulting from exposure to LPS is observed in rat primary
BMEC, and the present data are in agreement with that
obtained in cell lines of rat, bovine and human BMEC [38,40].
UCB-induced apoptosis, based on analysis of nuclear morphol-
ogy with Hoechst staining and confirmed by caspase-3 activity,
is in line with our previous observations in a human BMEC line
treated with UCB [27], as well as with those of Akin et al. [41]
in bovine BMEC. An interesting observation from this study is
that the cell damage shown by LDH release, apoptotic cell
death and caspase-3 activation tend to be higher and occur
earlier in UCB-treated cells than in LPS-exposed ones.
Accordingly, LPS did not further enhance UCB-induced cell
demise. On the other hand, while no significant apoptosis or
Figure 4. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) disrupt ultrastructure of brain endothelial cells. Cells were
treated with no addition (control) (A,D,E), LPS (B,F,G) or UCB (C,H,I) and were analyzed by transmission electron microscopy. Black arrows, tight
intercellular junctions; grey arrows, disruption of the plasma membrane; arrowheads, invaginations of the plasma membrane; a, apoptotic cells
bodies; m, mitochondria; N, cell nuclei; RER, rough endoplasmic reticulum; v, vacuole. Representative results from one of four independent
experiments are shown.
doi:10.1371/journal.pone.0035919.g004
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co-exposed to both insults at this time-point exhibited a similar
profile to that of UCB.
P-gp is an important efflux transporter at the BBB, which
protects the nervous system from toxic compounds. Therefore, its
inhibition compromises brain protection and promotes toxicity.
The retention of R123 by LPS in our experiments reflects an
impairment of the transporter activity and confirms previous
reports obtained both in vitro [10,42] and in vivo [43,44]. The data
collected also revealed an inhibition of P-gp activity by UCB,
which is a substrate of P-gp in bovine BMEC [45]. Brain UCB
levels were increased in P-gp deficient mice [46] and in rats treated
by P-gp inhibitors [46,47]. It is interesting to point out that
ongoing studies in our laboratory revealed higher expression of P-
gp in the brain parenchyma (endothelial cells, astrocytes and
neurons) of a human newborn infant who died from kernicterus,
the most severe pathologic outcome of hyperbilirubinemia
(unpublished data). These results suggest that the increase in P-
gp expression may be a compensatory mechanism to overcome the
lack of efficiency in its activity at the BBB. On the other hand, if
UCB levels inside endothelial cells are extremely elevated, the
transporter might not have the capacity to export both UCB and
R123 simultaneously, resulting in higher R123 contents.
MMPs are a family of proteases, important in normal
development and in endothelial cell migration given their ability
to degrade the ECM surrounding BBB capillaries [48]. As ECM
plays an important role in the induction of BBB properties [1], the
activity pattern of secreted MMPs after exposure to LPS and/or
UCB was investigated in the present study. Both MMP-2 and
MMP-9 have similar activity patterns, which may be due to
a homologous function. Our data are in agreement with previous
studies where it has been proven that exposure to LPS results in
enhanced secretion of active MMP-2 in human umbilical vascular
endothelial cells [49], and that microglial cells treated by UCB
secrete active MMP-2 and MMP-9 [26]. Released MMPs may
lead to degradation of the ECM and weaken the barrier properties
of the BBB by impairing the integrity of the basement membrane
[50], which might then favor the access of neurotoxins to the
brain. Interestingly, activation of MMPs is more marked at 4 h
than at 24 h, consistent with the striking alterations observed at
earlier time for permeability and TEER.
Ultrastructural analysis has indicated that apoptotic cell bodies
are visible following both LPS and UCB treatments, supporting
our apoptosis data obtained by fluorescence microscopy. All
treated cells presented disruption of the organelles, but it was
interesting to notice that the impairment of ultrastructure was
more marked for UCB than for LPS. This observation is consistent
with the greater extent of apoptotic and necrotic-like cell death by
UCB and might be related to UCB interaction with cell
membranes and perturbation of their dynamic properties that
we have previously demonstrated [51,52]. Another important
observation is the enhanced formation of caveolae-like structures
after LPS exposure, in line with previous observations in rats
[53,54]. Caveolin-1 plays an important role in capillary formation
and, when up-regulated, it activates MMP-2 and MMP-9 [49,55].
These MMPs were particularly amplified after exposure to LPS for
4 h, thus pointing to a possible relation between these partners.
Rat BMEC exposed to LPS still present TJs, though the TJ-
stiched membrane length appeared shorter compared to untreated
samples, whereas TJs are hardly visible in UCB-treated cells. This
observation may suggest that paracellular passage of UCB across
the endothelial monolayer may be facilitated. Although a TEM
study by Bo ¨hm et al. [56] reported UCB-induced damage of both
cell and nuclear membranes in human basal skin cells, as far as we
know, this is the first report describing UCB-induced ultrastruc-
tural alterations in endothelial cells forming the BBB.
Our permeability results on brain endothelial mono-cultures are
in line with those recently obtained by He and collaborators [57],
where a short exposure to LPS induced hyperpermeability and
TEER decrease in a BMEC line. Moreover, a study reports that
TLR4 and CD14 mRNA levels increase up to 3 h after LPS
exposure and then gradually decrease, though remaining detect-
able for up to 9 h [8]. This observation might explain why LPS
effects in mono-cultures become less marked as the incubation is
prolonged. This fact, together with the higher activity of MMPs by
a short exposure, shall then contribute to the greatest impairment
of barrier indicators observed at 4 h. In co-cultures, the present
results are supported by our previous reports that LPS elevates
permeability and decreases TEER [10]. It has been long stated
that astroglial cells strengthen BMEC barrier properties [1,29,33]
and prevent the increase of endothelial permeability after several
stimuli, such as hypoxia or ischemia [58,59]. The protective effect
of glial cells against LPS-mediated injury was also demonstrated in
bovine brain endothelial cells [60]. Nonetheless, it has been
proven that, in inflammatory conditions, astrocytes increase
human BMEC permeability via IL-1b secreted to the cell culture
supernatant and this could be reversed through a monoclonal
antibody against IL-1b [61]. Regarding UCB, no former studies
have been performed on its effects on brain endothelial barrier
properties. Raimondi et al. [62] demonstrated that exposure of
human intestinal cell line Caco-2 to UCB decreases transepithelial
electrical resistance and increases the paracellular flux of 10 kDa
Figure 5. Lipopolysaccharide (LPS) and unconjugated bilirubin
(UCB) disrupt the endothelial monolayer. Permeability to sodium
fluorescein (Na-F_Pe) (A) and transendothelial electrical resistance
(TEER) (B) were determined after exposure. All values presented are
means 6 S.E.M. from at least four independent experiments performed
in duplicate. *P,0.05, **P,0.01 and ***P,0.001 vs. respective control;
1P,0.05 vs. LPS at the same time-point;
#P,0.05 from 4 h.
doi:10.1371/journal.pone.0035919.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e35919Figure 6. Effects of lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) on endothelial integrity in mono-cultures and co-
cultures. Permeability to sodium fluorescein (Na-F_Pe) (A, B) and transendothelial electrical resistance (TEER) (C, D) were determined in mono-
cultures (A,C) and co-cultures (B,D) after 24 h exposure. All values presented are means 6 S.E.M. from at least two independent experiments
performed in triplicate. **P,0.01 and ***P,0.001 vs. respective control;
11P,0.01 and
111P,0.001 vs. LPS at the same time-point.
doi:10.1371/journal.pone.0035919.g006
Figure 7. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) modify the distribution of b-catenin in brain endothelial cells.
Cells in mono-culture or co-cultured with astrocytes were fixed and immunostained with an antibody against b-catenin to evaluate its cellular
localization (scale bars, 40 and 20 mm, respectively). Disruption of the monolayer with gaps between endothelial cells (*), alterations in protein
patterns (arrowheads) with the presence of dot-like staining (yellow arrow), and perinuclear distribution (arrows) are indicated. Representative results
from one of two independent experiments are shown.
doi:10.1371/journal.pone.0035919.g007
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UCB-induced decrease in TEER and increase in permeability are
consistent with the data found in Caco-2 epithelial cells [62].
Unlike the intestinal cells, rat BMEC monolayers do not recover at
later time-points, indicating high endothelial sensitivity to UCB
toxicity and a greater potential of UCB for neurotoxicity.
Endothelial cells treated with both compounds for 24 h displayed
more serious barrier dysfunction as compared with LPS alone,
pointing to a failure of the recovery process that might happen
when sepsis occurs simultaneously with hyperbilirubinemia. IL-6 is
released by human BMEC, which additionally produce nitric
oxide [27], a molecule that contributes to enhance the perme-
ability of the barrier [1]. Rat BMEC produce prostacyclin, as we
have previously demonstrated [63]. Thus, changes in prostanoid,
especially prostacyclin synthesis [64] may also contribute to the
observed endothelial permeability alterations. Interestingly, an
increased permeability and a decreased TEER were also observed
when each of the neurotoxins, or their combination, were added to
BMEC in co-culture with astrocytes. This observation, relying in
an in vitro model that more closely resembles the in vivo condition,
reinforces the data obtained in the simpler model of the BBB
composed of BMEC alone.
Analysis of the AJ protein distribution pattern revealed
a decreased localization at intercellular junctions at 4 h exposure
to LPS, UCB or their combination, which is partially reversed at
24 h, as well as a disorganization of the endothelial sheet,
particularly evident in co-cultured cells. Also interesting was the
perinuclear accumulation of b-catenin, which was associated with
a disruption of the VE-cadherin/b-catenin complexes during
inflammation [65,66]. Therefore, the production of cytokines by
astrocytes and BMEC exposed to LPS or UCB [27,32,67,68] may
contribute to this process, which brings new insights into the
mechanisms of toxicity by these compounds. Since Wnt signaling
pathway activation is recognized as a mechanism of cell survival
involved in the expression of TJ-associated proteins [69], the
present observations suggest an attempt to compensate the loss of
integrity resulting from exposure to the insults.
Figure 8. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) alter zonula occludens-1 (ZO-1) expression in brain endothelial
cells. Cells, either in mono-culture or co-cultured with astrocytes, were fixed and immunostained with an antibody against ZO-1 to evaluate its
cellular localization and pattern of expression, as well as integrity of the monolayer. Disruption of the monolayer with gaps between endothelial cells
(*), alterations in protein patterns (arrowheads) and perinuclear distribution (arrows) are indicated. Representative results from one of two
independent experiments are shown. Scale bar, 20 mm.
doi:10.1371/journal.pone.0035919.g008
Figure 9. Lipopolysaccharide (LPS) and unconjugated bilirubin (UCB) alter expression of claudin-5 in brain endothelial cells. Cells,
either in mono-culture or co-cultured with astrocytes, were fixed and immunostained with an antibody against claudin-5 to evaluate its cellular
localization, pattern of expression and integrity of the monolayer. Disruption of the monolayer with gaps between endothelial cells (*) and alterations
in protein patterns (arrowheads) are indicated. Representative results from one of two independent experiments are shown. Scale bar, 20 mm.
doi:10.1371/journal.pone.0035919.g009
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claudin-5 are also affected by the tested neurotoxins. The
accumulation of these proteins in the plasma membrane of co-
cultured control cells, compared to mono-cultured cells is in line
with the astrocytic induction of barrier properties in endothelial
cells in vitro [1,29,33]. It may also be related with the low serum
concentration used in this study, as astrocyte co-cultures in the
absence of serum in the basolateral compartment result in higher
BMEC barrier indices, given their greater resemblance to the
in vivo microenvironment [70]. Our mono-culture results confirm
that LPS treatment alters intercellular junctions that are associated
with BBB impairment [71]. UCB-treated cells also show a re-
distribution of TJs proteins similarly to what was seen for occludin
in epithelial cells [62]. The segmentation of claudin-5 immunos-
taining pattern may be related to the secretion of active MMPs, as
it was described for occludin [72,73]. Considering that Yang et al.
[74] have reported a reduction of claudin-5 mRNA in mice
following an increase in MMP-2 expression, it is conceivable that
activation of MMPs might be related to the loss of claudin-5. To
the impairment of TJs and consequent increase in permeability
may also account nitric oxide [75], which is produced by exposure
of BMEC and glial cells to UCB or LPS [10,27,76].
The increase in the permeability of co-cultured rat BMEC
exposed to the neurotoxins might be related to the alterations in
the pattern of expression and cellular localization of ZO-1 and
claudin-5, already demonstrated at earlier time-points [10]. In
fact, the mRNA contents of TJ proteins ZO-1 and claudin-5, as
well as their cellular localization decrease in bovine retinal
endothelial cells treated by IL-1b and TNF-a [77], which are
known to be secreted by astrocytes. The translocation of ZO-1
from the membrane to the nucleus has never been reported in
endothelial cells treated with LPS. Still, a recent paper by Zhong
and collaborators [78] describes that ZO-1 is present in small
concentrations in the nuclei, even in untreated cells. Therefore,
our results are in agreement with the dual role of ZO proteins
[79], and the evident increase of the perinuclear staining brings
new insights into a possible translocation of ZO-1 to the nucleus or
acting as a nuclear factor during inflammation in the presence of
astrocytes. Its dissociation from the junctional complexes is related
with increased barrier permeability [80], which may further
explain the mechanism for enhanced permeability in co-cultures.
The same permeability enhancement in UCB-treated cells can
also be related to the redistribution of claudin-5, an important
contributor to TJs seal [1].
Conclusions
The present data prove that LPS and UCB alter various aspects
in rat BMEC. We can conclude that these neurotoxins diminish
the viability of brain endothelial cells and alter BBB functions by
inhibiting P-gp activity and inducing the secretion of active
MMPs. Ultrastructural analysis detected newly formed caveolae-
like structures and damage of organelles, like mitochondria and
rough endoplasmic reticulum, which may be involved in the
mechanisms of action of these neurotoxins. Moreover, this is the
first study to demonstrate that paracellular permeability, TEER
and intercellular junctions are altered by these compounds in rat
BMEC either in mono-cultures or in co-culture with astrocytes.
At last, our study revealed that each of the compounds has its
own mechanism of action and temporal profile, comprising cell
death (early occurring for UCB and only lately for LPS), the
impairment of barrier properties (sustained along time for UCB
but not for LPS), the distribution pattern of intercellular junctions
as b-catenin (opposite variations in fluorescence intensity for UCB
and LPS) and ultrastructural alterations (shortened intercellular
junctions and the increased number of caveolae particularly
evident in LPS-treated cells). Collectively, by compromising the
BBB integrity, the alterations resulting from exposure to LPS and/
or UCB may facilitate the access of the compounds to the brain
further contributing to their neurotoxicity.
Materials and Methods
Cell Cultures
Animal care followed the recommendations of European
Convention for the Protection of Vertebrate Animals Used for
Experimental and other Scientific Purposes (Council Directive 86/
609/EEC) and National Law 1005/92 (rules for protection of
experimental animals). Formal approvals to conduct all animal
procedures in the experiments have been obtained from the
Animal Experimentation Committee of the Biological Research
Centre, Hungarian Academy of Sciences (Hungary), and from the
local authorities (Permit number: XVI./03835/001/2006).
Primary cultures of rat BMEC were prepared from 2-week-old
Wistar rats, as previously described [10,81,82]. Briefly, meninges
were removed from forebrains and gray matter was minced into
small pieces in Dulbecco’s modified Eagle’s medium (DMEM)/
Ham’s F12 (DMEM/F12, Biochrom AG, Germany), and digested
in DMEM/F12 containing 1 mg/ml collagenase CLS2
(Worthington, USA) for 1.5 h at 37uC. Cell pellet was separated
by centrifugation in 20% bovine serum albumin-DMEM/F12
(10006g, 20 min). Microvessels were further digested with 1 mg/
ml collagenase-dispase (Roche Applied Sciences, Switzerland) in
DMEM/F12 for 1 h at 37uC. Microvessel endothelial cell clusters
were separated on a 33% continuous Percoll (Pharmacia, Sweden)
gradient, collected and washed in DMEM/F12 before plating
(1.5610
5 cells/cm
2) onto collagen type IV and fibronectin coated
cell culture inserts or multiwell plates. Cultures were maintained in
DMEM/F12 supplemented with 15% fetal bovine serum (FBS)
(Biochrom AG), 1 ng/ml basic fibroblast growth factor (Roche
Applied Sciences), 100 mg/ml heparin (Biochrom AG), 5 mg/ml
gentamycin and 4 mg/ml puromycin [81] (medium I) at 37uC with
a humidified atmosphere of 5% CO2, for 2 days. On day 3, cells
received new medium, which contained all components of
medium I except puromycin (medium II).
Primary cultures of glial cells were prepared from newborn
Wistar rats [10,81,82]. Meninges were removed, and cortical
pieces were mechanically dissociated in DMEM containing 5 mg/
ml gentamicin and 10% fetal bovine serum and plated in poly-L-
lysin coated 12-well dishes and kept for minimum 3 weeks before
use. In confluent astroglia cultures 90% of cells were immunopo-
sitive for the astroglia cell marker glial fibrillary acidic protein,
while the remaining 10% was immunopositive for CD11b,
a marker of microglia.
For co-culture, BMEC in cell culture inserts were placed into
multiwells containing glia at the bottom of the wells with
endothelial culture medium in both compartments. When BMEC
became almost confluent 550 nM hydrocortisone was added to the
culture medium [83], for 1 day.
Treatment of Endothelial Cells
UCB (Sigma-Aldrich, USA), was purified according to the
method of McDonagh and Assisi [84] and stock solutions were
extemporarily prepared in 0.1 M NaOH, under light protection,
and the pH adjusted to 7.4 by addition of equal amounts of 0.1 M
HCl. A stock solution of LPS (Escherichia coli O111:B4; Calbio-
chem, Germany) was prepared in PBS. Confluent monolayers of
rat BMEC received medium II with 2% FBS, and were divided
into four groups: untreated cells (control), 1 mg/ml LPS, 50 mM
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V, fatty acid free, Sigma-Aldrich), or a combination of both, for
4 h and 24 h at 37uC. The concentration of LPS was selected to
mimic sepsis [85–87] and was shown to induce damage to rat
BMEC in our previous study [10]. The use of albumin mimics the
in vivo condition, where there is equilibrium between the bilirubin
fraction that is bound to albumin, the one that is free in circulation
and the one that binds to cells. Therefore, albumin functions as
a sink for bilirubin, so that bilirubin may be continuously released
from albumin as it binds to cells, therefore perpetuating the
fraction that is available for interaction with cells and thus
enhancing the effects. The UCB condition mimics moderate to
severe hyperbilirubinemia in a term or a preterm infant,
respectively [88]. In fact, studies performed in our lab showed
that a group of full term neonates with moderate jaundice present
a molar ratio of 0.42 (,195 mM bilirubin and ,445 mM serum
albumin) [89], and that a preterm infant with a bilirubin to
albumin molar ratio of 1.0 (,493 mM bilirubin and ,498 mM
serum albumin) at the second day of life dyed on the fourth with
the diagnosis of kernicterus [90]. In the present experimental
conditions, the concentration of unbound UCB (free UCB),
determined by the peroxidase method [91], was 12 nM, which is
close to the 19 nM value found in the moderate jaundiced infants
studied [89]. The absence of biliverdin in the UCB-treated
samples was assured by continuous absorbance spectra from 300
to 800 nm [92], which revealed no peaks at 380 and 665 nm.
Cell Death Evaluation
Standard evaluation of rat BMEC cytotoxicity was performed
by measuring the release of LDH from cells with damaged plasma
membrane into the incubation medium using a cytotoxicity
detection kit (Roche Molecular Biochemicals, Germany), as
previously described [39]. The reaction was performed in a 96-
well microplate and the absorbance measured at 490 nm, using
a PR 2100 microplate reader from Bio-Rad (USA). All readings
were corrected for possible interference of UCB absorption and
the results expressed as percent of LDH release. Cytotoxicity was
calculated as percentage of the total LDH release from untreated
cells lysed with 2% Triton X-100 for 30 min. To evaluate
apoptosis, cells fixed in freshly prepared 4% paraformaldehyde
solution in phosphate buffer saline (PBS) were immunostained
with Hoechst 33258 dye for 2 min at room temperature, and
mounted in Glycerol Mount. Apoptotic nuclei were identified by
condensed chromatin or nuclear fragmentation, and counted for
each independent experiment in at least five random microscopic
fields (4006) per sample, as described previously [32], using a Leica
DFC 490 camera (Leica, Germany) adapted to an AxioScope.A1
microscope (Zeiss, Germany). Although the fluorescence emission
of Hoescht 33258 dye at 461 nm overlaps with the absorption of
UCB at 460 nm, the possible quenching by UCB absorption does
not interfere with the obtained results since apoptosis was
evaluated based on morphology and not on fluorescence intensity.
Activity of caspase-3 was measured by a colorimetric method
(Calbiochem, Darmstadt, Germany), as usual in our lab [27].
Briefly, cells were harvested, washed with ice-cold PBS, and lysed
for 30 min, on ice, in the lysis buffer [50 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (pH 7.4); 100 mMNaCl; 0.1%
(w/v) cholamidopropyldimethylammonio-1-propanesulfonate;
1 mM dithiothreitol; 0.1 mM ethylenediaminetetraacetic acid].
The lysate was centrifuged at 10,0006g for 10 min at 4uC and the
supernatants were collected and stored at 280uC. The activity of
caspase-3 was determined by enzymatic cleavage of chromo-
phorep NA from the substrate, according to manufacturer’s
instructions. The proteolytic reaction was carried out in protease
assay buffer [50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfo-
nic acid (pH 7.4); 100 mM NaCl; 0.1% (w/v) cholamidopropyldi-
methylammonio-1-propanesulfonate; 10 mM dithiothreitol;
0.1 mM ethylenediaminetetraacetic acid; 10% (v/v) glycerol],
containing 2 mM substrate Ac-DEVD-pNA. Following incubation
of the reaction mixtures for 2 h at 37uC, the formation of pNA was
measured at 405 nm with a reference filter of 620 nm. The results
were expressed as relative activity vs. control samples.
Functional Assay for P-gp
Activity of P-gp was determined by measuring cellular
accumulation of the P-gp substrate R123 per mg of protein
content [10], and results were expressed as fold-change as
compared to the respective control. In brief, treated rat BMEC
were washed, and incubated for 1 h at 37uC with Ringer–Hepes
solution (118 mM NaCl, 4.8 mM KCl, 2.5 mM CaCl2, 1.2 mM
MgSO4, 5.5 mM D-glucose, 20 mM Hepes, pH 7.4) containing
10 mM R123. The solution was quickly removed, rat BMEC were
washed three times with PBS and solubilized in 0.1 M NaOH.
R123 content was determined using a Polarstar Galaxy fluorescent
plate reader (BMG Labtechnologies; excitation at 505 nm,
emission at 538 nm). The fluorescence emission of R123 is not
quenched by bilirubin’s absorption, as the absorption of UCB is at
460 nm. Verapamil (100 mM, 30 min pre-incubation) was used as
a reference P-gp inhibitor for the positive control (1.9-fold at 4 h
and 2.8-fold at 24 h). Protein content was evaluated by the
Bradford method [93] using Bio-Rad’s Protein Assay reagent (Bio-
Rad).
Gelatin Zymography
Determination of MMP-2 and MMP-9 was evaluated as
previously described [26]. In short, aliquots of culture supernatants
were analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) zymography in 0.1% gelatine–10%
acrylamide gels under non-reducing conditions. After electropho-
resis, gels were washed for 1 h with 2.5% Triton X-100 (in
50 mMTris pH 7.4, 5 mM CaCl2,1mM ZnCl2) to remove SDS
and renature the MMPs species in the gel. Then the gels were
incubated in the developing buffer (50 mM Tris pH 7.4, 5 mM
CaCl2,1mM ZnCl2) overnight to induce gelatin lysis. For enzyme
activity analysis, the gels were stained with 0.5% Coomassie
Brilliant Blue R-250 (Bio-Rad) and destained in 30% ethanol/
10% acetic acid/H2O. Gelatinase activity, detected as a white
band on a blue background, was quantified by computerized
image analysis and normalized with total cellular protein using
Quantity One 1-D Analysis Software (Bio-Rad).
TEM Analysis
Rat BMEC mono-cultures grown on inserts were fixed with
freshly prepared 4% paraformaldehyde in 0.05 M cacodylate
buffer (pH 7.5) for 30 min at 4uC. After washing with cacodylate
buffer several times, the membranes of the cell culture inserts with
the cells were removed from their support and placed into 24-well
chamber slide and were post-fixed in 1% OsO4 for 30 min.
Following washing with distilled water, the cells on the membrane
were dehydrated in graded ethanol, block-stained with 1% uranyl
acetate in 50% ethanol for 30 min and embedded in Taab 812
(Taab; Aldermaston, UK). Following polymerization at 60uC for
12 h, 50–60 nm ultrathin sections were cut perpendicularly for the
membrane using a Leica UCT ultramicrotome (Leica Micro-
systems, UK) and examined using a Hitachi 7100 transmission
electron microscope (Hitachi Ltd., Japan). Electron micrographs
were made by Veleta, a 2 k62 k MegaPixel side-mounted TEM
CCD camera (Olympus). Electron micrographs were edited by
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Evaluation of the Monolayer Integrity
The flux of Na-F (MW: 376 Da) across endothelial monolayers
and co-cultures was determined as previously described [10,82].
Briefly, cell culture inserts were transferred to 12-well plates
containing 1.5 ml Ringer–Hepes solution in the abluminal
compartments. Culture medium from luminal compartments
was replaced by 0.5 ml Ringer–Hepes solution containing
10 mg/ml Na-F. Inserts were transferred at 20, 40 and 60 min
to new wells containing Ringer–Hepes solution. Na-F levels were
measured using a Hitachi F-2000 fluorescence spectrophotometer
(excitation: 440 nm, emission: 525 nm). Flux across cell-free
inserts was also measured. Endothelial permeability coefficient
was calculated as previously described [10,29] and results were
expressed in cm/s or as fold-change compared to the respective
control. TEER of mono-cultures and co-cultures, reflecting the
paracellular permeability for mainly sodium ions in the present
culture conditions, was measured using a STX-2 electrode coupled
to an EVOM resistance meter (World Precision Instruments,
USA). TEER readings of cell-free inserts (,100 V cm
2) were
subtracted from the values obtained with cells. For comparison of
the data between mono-cultures and co-cultures TEER of cells
treated with no addition (control) was considered 100%.
Immunostaining for Intercellular Junctions
BMEC in mono-culture or co-cultured with astrocytes were
stained for junctional proteins ZO-1, claudin-5 and b-catenin.
Cultures were washed in PBS and fixed with ethanol (95%)–acetic
acid (5%) (v/v) for 10 min at 220uC [10]. Cells were blocked with
3% BSA and incubated with primary antibodies anti-ZO-1
(1:200), anti-claudin-5 (1:200), and anti-b-catenin (1:200) (Invitro-
gen, USA) overnight at 4uC. Incubation with secondary antibody
Cy3-labelled anti-rabbit IgG (1:200) (GE Healthcare, UK) and
Alexa 488 anti-mouse IgG (1:500) (Invitrogen) lasted for 1 h at
room temperature. Nuclei were counterstained with Hoechst
33258 dye. Between incubations cells were washed three times
with PBS. Coverslips were mounted in Gel Mount (Biomeda,
USA) and staining was examined by a Nikon Eclipse TE2000
fluorescent microscope (Nikon, Japan) and photographed using
a Spot RT digital camera (Diagnostic Instruments, USA) or using
a Leica DFC 490 camera (Leica, Germany) adapted to an
AxioScope.A1 microscope (Zeiss, Germany). Evaluation of
fluorescence intensity of b-catenin in mono-cultures was de-
termined using ImageJ 1.296software (N.I.H., USA) and results
were expressed as fold change (mean fluorescence per number of
cells vs. control samples).
Statistical Analysis
Results of at least three different experiments were expressed as
mean 6 S.E.M. Differences between groups were determined by
one-way ANOVA using Prism 5.0 (GraphPad Software, San
Diego, CA) followed by multiple comparisons Bonferronipost-hoc
correction. Statistical significance was considered when P values
were lower than 0.05.
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